A customizable P hydrogel applicator for brachytherapy of skin hemangioma based on machine learning and 3D-printing.

Journal: Journal of materials chemistry. B
PMID:

Abstract

Skin hemangioma is a tumor originating from skin blood vessels, which often occurs in infants and children. Brachytherapy with the P-based radionuclide applicator is an effective non-invasive therapeutic method. However, the inordinance of lesions is still the main challenge for precise local treatment and radiation protection of normal skins. A radionuclide applicator possessing advanced shape adaptability, favorable radionuclide biodistribution, optimized stress feature, and convenient preparation method is highly required for clinical practice. Herein, we present a customizable polyacrylamide (PAAm) hydrogel-based radionuclide applicator, integrating automatic lesion recognition machine learning and 3D printing technology. The machine learning algorithm achieved a geometric accuracy of 98.78% in automated lesion contour recognition, providing guaranteed data support for 3D printing. The optimized hydrogel exhibited excellent mechanical properties (elastic modulus: 228 kPa, fracture toughness: 4.51 MJ m), rapid curing (<10 min), and promising P loading efficiency (>85%). Especially, this system greatly shortened the fabrication time while ensuring precise geometric matching for complex lesions. Through cell and tumor-bearing mouse models, the hydrogel loaded with P (P-HG) demonstrated favorable biocompatibility and effective therapeutic efficacy. It is believed that the synergy of intelligent recognition, 3D printing, and enhanced hydrogel performance can establish a promising treatment method with great practical potential for precise fitting brachytherapy of skin hemangioma.

Authors

  • Jingyu Wang
    Center of Medical & Health Analysis, School of Public Health, Peking University, Beijing, China.
  • Rang Wang
    Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu 610041, China. huawei.cai@wchscu.edu.cn.
  • Peng Chen
  • Lisha Jiang
    Laboratory of Clinical Nuclear Medicine, Department of Nuclear Medicine, West China Hospital of Sichuan University, No. 37 Guo Xue Alley, Chengdu, 610041, People's Republic of China.
  • Banggan Luo
    College of Polymer Science and Engineering, National Key Laboratory of Advanced Polymer Materials, Sichuan University, Chengdu 610065, China. xuyt@scu.edu.cn.
  • Xueqian Zhang
    College of Polymer Science and Engineering, National Key Laboratory of Advanced Polymer Materials, Sichuan University, Chengdu 610065, China. xuyt@scu.edu.cn.
  • Wanjie Bai
    College of Polymer Science and Engineering, National Key Laboratory of Advanced Polymer Materials, Sichuan University, Chengdu 610065, China. xuyt@scu.edu.cn.
  • Ting Zhang
    Beijing Municipal Key Laboratory of Child Development and Nutriomics, Capital Institute of Pediatrics, Beijing 100020, China.
  • Jinsong Zhang
    Department of Emergency, Jiangsu Province Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China. zhangjso@njmu.edu.cn.
  • Shu Tan
    Nuclear Power Institute of China, Chengdu 610101, China.
  • Rong Tian
    Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu 610041, China. Electronic address: rongtiannuclear@126.com.
  • Yiwen Li
    College of Polymer Science and Engineering, National Key Laboratory of Advanced Polymer Materials, Sichuan University, Chengdu 610065, China. xuyt@scu.edu.cn.
  • Huawei Cai
    Department of Nuclear Medicine, West China Hospital of Sichuan University, Chengdu 610041, PR China. Electronic address: hw.cai@yahoo.com.
  • Yuanting Xu
    College of Polymer Science and Engineering, National Key Laboratory of Advanced Polymer Materials, Sichuan University, Chengdu 610065, China. xuyt@scu.edu.cn.